The Porphyrias | Williams Manual of Hematology, 9e | AccessHemOnc

INTRODUCTION

The porphyrias are inherited or acquired disorders in which the activity of an enzyme in the heme biosynthetic pathway is altered. Metabolic intermediates are produced in excess, initially either in the marrow or the liver, and result in neurologic and/or photocutaneous symptoms and signs.

CLASSIFICATION

See Table 28–1.
The two organs most active in heme biosynthesis are the marrow and the liver. Photosensitivity (indicated below with the following symbols as either blistering^* or nonblistering^†) and/or (indicated below with the following symbol as) neurovisceral symptoms^‡ may be part of the porphyria phenotype. Therefore, porphyrias are classified as erythropoietic or hepatic and as cutaneous or acute.

TABLE 28–1HUMAN PORPHYRIAS: SPECIFIC ENZYMES AFFECTED BY MUTATIONS, MODES OF INHERITANCE, CLASSIFICATION, AND MAJOR CLINICAL FEATURES OF EACH OF THE HUMAN PORPHYRIAS

View Table|Favorite Table|Download (.pdf)

TABLE 28–1 HUMAN PORPHYRIAS: SPECIFIC ENZYMES AFFECTED BY MUTATIONS, MODES OF INHERITANCE, CLASSIFICATION, AND MAJOR CLINICAL FEATURES OF EACH OF THE HUMAN PORPHYRIAS

Porphyria^a	Affected Enzyme	Known Mutations	Inheritance	Classification	Principal Clinical Features
X-linked protoporhyria (XLP)	δ-Aminolevulinic acid (ALA) synthase erythroid-specific form (ALAS2)	4 (gain of function)	Sex-linked recessive	Erythropoietic	Nonblistering photosensitivity
δ-Aminolevulinic acid dehydratase porphyria (ADP)	ALA dehydratase (ALAD)	10	Autosomal recessive	Hepatic^b	Neurovisceral
Acute intermittent porphyria (AIP)	PBG deaminase (PBGD)	273	Autosomal dominant	Hepatic	Neurovisceral
Congenital erythropoietic porphyria (CEP)	Uroporphyrinogen III synthase (UROS)	36	Autosomal recessive	Erythropoietic	Neurovisceral
Porphyria cutanea tarda (PCT)	Uroporphyrinogen decarboxylase (UROD)	70 (includes HEP)	Autosomal dominant^c	Hepatic	Blistering photosensitivity
Hepatoerythropoietic porphyria (HEP)	UROD	—	Autosomal recessive	Hepatic^b	Blistering photosensitivity
Hereditary coproporphyria (HCP)	Coproporphyrinogen oxidase (CPO)	42	Autosomal dominant	Hepatic	Neurovisceral; blistering photosensitivity (uncommon)
Variegate porphyria (VP)	Protoporphyrinogen oxidase (PPO)	130	Autosomal dominant	Hepatic	Neurovisceral; blistering photosensitivity (common)
EPP – classic form	Ferrochelatase (FECH)	90	Autosomal recessive^d	Erythropoietic	Nonblistering photosensitivity

^aPorphyrias are listed in the order of the affected enzyme in the heme biosynthetic pathway.

^bThese porphyrias also have erythropoietic features, including increases in erythrocyte zinc protoporphyrin.

^cHeterozygous UROD mutations are present in familial (type 2) but not in the more common sporadic (type 1) PCT. In all cases, an acquired inhibition of hepatic UROD reduces the enzyme activity to less than ~20% of normal.

^dBecause both alleles are abnormal in affected individuals (in most cases with a severe FECH mutation trans to a hypomorphic FECH allele), EPP is now regarded as recessive at the molecular level.

Source: Williams Hematology, 9th ed, Chap. 58, Table 58–1.

Erythropoietic Porphyrias

Principal site of initial accumulation of pathway intermediates: the erythroblast
Congenital erythropoietic porphyria (CEP)^*
Erythropoietic protoporphyria (EPP)^†
X-linked protoporphyria (XLP)^†

Hepatic Porphyrias

Principal site of initial accumulation of pathway intermediates: the liver
δ-Aminolevulinic acid dehydratase porphyria (ADP)^‡
Acute intermittent porphyria (AIP)^‡
Hereditary coproporphyria (HCP)^*‡
Variegate porphyria (VP)^...

GET ACCESS TO THIS RESOURCE

Sign In

Username

Password

Forgot Username? Forgot Password?

Get Free Access Through Your Institution

Contact your institution's library to ask if they subscribe to McGraw-Hill Medical Products.

What is MyAccess?

Use this site remotely
Bookmark your favorite content
Track your self-assessment progress
and more!

Chapter 28: The Porphyrias

Citation

INTRODUCTION

CLASSIFICATION

Erythropoietic Porphyrias

Hepatic Porphyrias

Pop-up div Successfully Displayed